{"product_id":"cjc-5mg","title":"CJC (No DAC) 10mg","description":"\u003ch2 data-start=\"137\" data-end=\"206\"\u003e\u003cstrong data-start=\"140\" data-end=\"206\"\u003eCJC (No DAC) 10mg\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp data-start=\"208\" data-end=\"470\"\u003eCJC (No DAC) 5mg is supplied strictly as a \u003cstrong data-start=\"251\" data-end=\"282\"\u003elaboratory research peptide\u003c\/strong\u003e for analytical and scientific use only. Available to \u003cstrong data-start=\"336\" data-end=\"393\"\u003equalified researchers, laboratories, and institutions\u003c\/strong\u003e in Perth and across Western Australia, with \u003cstrong data-start=\"438\" data-end=\"469\"\u003eAustralian-based fulfilment\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp data-start=\"472\" data-end=\"649\"\u003eIntended for \u003cstrong data-start=\"485\" data-end=\"506\"\u003ein-vitro research\u003c\/strong\u003e, \u003cstrong data-start=\"508\" data-end=\"529\"\u003eassay development\u003c\/strong\u003e, \u003cstrong data-start=\"531\" data-end=\"552\"\u003emethod validation\u003c\/strong\u003e, and \u003cstrong data-start=\"558\" data-end=\"597\"\u003econtrolled scientific investigation\u003c\/strong\u003e conducted by appropriately qualified professionals.\u003c\/p\u003e\n\u003ch3 data-start=\"651\" data-end=\"674\"\u003e\u003cstrong data-start=\"655\" data-end=\"674\"\u003eProduct details\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp data-start=\"677\" data-end=\"704\"\u003e\u003cstrong data-start=\"677\" data-end=\"689\"\u003eProduct:\u003c\/strong\u003e CJC -1295 NO DAC (Mod GRF (1-29))\u003c\/p\u003e\n\u003cul\u003e\n\u003cli data-start=\"707\" data-end=\"734\"\u003e\n\u003cstrong data-start=\"707\" data-end=\"727\"\u003eStrength \/ size:\u003c\/strong\u003e 10 mg\u003c\/li\u003e\n\u003cli data-start=\"737\" data-end=\"791\"\u003e\n\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e \u003cspan\u003eC\u003c\/span\u003e\u003csub\u003e152\u003c\/sub\u003e\u003cspan\u003eH\u003c\/span\u003e\u003csub\u003e252\u003c\/sub\u003e\u003cspan\u003eN\u003c\/span\u003e\u003csub\u003e44\u003c\/sub\u003e\u003cspan\u003eO\u003c\/span\u003e\u003csub\u003e42\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"737\" data-end=\"791\"\u003e\n\u003cmeta charset=\"UTF-8\"\u003e \u003cstrong\u003eSynonyms:\u003c\/strong\u003e Mod GRF (1-29)\u003c\/li\u003e\n\u003cli data-start=\"737\" data-end=\"791\"\u003e\n\u003cstrong data-start=\"737\" data-end=\"750\"\u003eCategory:\u003c\/strong\u003e Research peptide \/ laboratory compound\u003c\/li\u003e\n\u003cli data-start=\"794\" data-end=\"829\"\u003e\n\u003cstrong data-start=\"794\" data-end=\"802\"\u003eUse:\u003c\/strong\u003e Laboratory research only\u003c\/li\u003e\n\u003cli data-start=\"832\" data-end=\"922\"\u003e\n\u003cstrong data-start=\"832\" data-end=\"850\"\u003eCertification:\u003c\/strong\u003e Certificate of Analysis (COA) \/ batch documentation (where available)\u003c\/li\u003e\n\u003cli data-start=\"925\" data-end=\"978\"\u003e\n\u003cstrong data-start=\"925\" data-end=\"936\"\u003eSupply:\u003c\/strong\u003e Perth \u0026amp; Western Australia (AU shipping)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cmeta charset=\"UTF-8\"\u003e\u003cstrong\u003eSEQUENCE:\u003c\/strong\u003e\u003cspan\u003e H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Mal)-NH2\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cmeta charset=\"UTF-8\"\u003eModified GRF (1-29), or Mod GRF (1-29), is a synthetic peptide that is a modified fragment of the endogenously occurring growth hormone-releasing hormone (GHRH). It was first developed in the 1980s when studies indicated that the first 29 amino acids of GHRH may possess all of the biological potential associated with the full-length 44 GHRH molecule.\u003cbr\u003e\u003cbr\u003eThis discovery led to the development of a truncated version called GRF (1-29), also referred to as Sermorelin by researchers. Mod GRF (1-29) introduces specific modifications to support the peptide's stability and efficacy. Four amino acids in the sequence are substituted at positions 2, 8, 15, and 27.  Here is what some researchers believe about these modifications:\u003cbr\u003e- Position 2: The amino acid alanine is replaced with its mirror image, D-alanine. This substitution aims to increase resistance to enzymatic degradation, thereby improving the peptide's stability.\u003cbr\u003e- Position 8: Asparagine is substituted with lysine, an amino acid with a positively charged side chain. This change may support the peptide's binding affinity to GHRH receptors, potentially increasing its biological activity.\u003cbr\u003e- Position 15: Histidine is replaced with D-phenylalanine, another D-amino acid. This modification is intended to protect the peptide from further enzymatic breakdown.\u003cbr\u003e- Position 27: Cysteine is substituted with N-methylglycine, also referred to as sarcosine. This alteration may extend the peptide's half-life by mitigating enzymatic cleavage.\u003cbr\u003e\u003cbr\u003eThese modifications collectively aim to produce a peptide with increased stability, a longer half-life, and better-supported interaction with GHRH receptors compared to the original GRF (1-29). Modified GRF (1-29) is structurally identical to CJC-1295 without DAC. The DAC in CJC-1295 serves to modify its pharmacokinetic properties.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"BioTech Perth","offers":[{"title":"Default","offer_id":45502636589229,"sku":"BTP-017","price":85.0,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0741\/3887\/8125\/files\/CJC_no_dac.png?v=1768263913","url":"https:\/\/perthbiotech.com\/products\/cjc-5mg","provider":"Perth BioTech - Perth’s trusted source for precision research peptides.","version":"1.0","type":"link"}